1. Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)
    Estelle Dhamelincourt et al, 2023, Targeted Oncology CrossRef